Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05499351
What this trial is testing

Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

Who this might be right for
COVID-19
Sinovac Biotech Co., Ltd 3,000
Testing effectiveness (Phase 2)Study completedNCT05903183
What this trial is testing

Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age

Who this might be right for
Healthy
Icosavax, Inc. 264
Early research (Phase 1)Study completedNCT02459262
What this trial is testing

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.

Who this might be right for
Infection by Streptococcus Group B
Minervax ApS 240
Post-approval studies (Phase 4)UnknownNCT06146088
What this trial is testing

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

Who this might be right for
Hand, Foot and Mouth Disease
Institute of Medical Biology, Chinese Academy of Medical Sciences 1,500
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Large-scale testing (Phase 3)Study completedNCT00429780
What this trial is testing

Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)

Who this might be right for
Healthy
Tehran University of Medical Sciences 100
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01692886
What this trial is testing

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

Who this might be right for
Pneumococcal Infection
Pfizer 1,674
Large-scale testing (Phase 3)Study completedNCT06066294
What this trial is testing

A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved.

Who this might be right for
Vaccine Reaction
Kempegowda Institute of Medical Sciences, Bangalore 144
Testing effectiveness (Phase 2)Study completedNCT05077267
What this trial is testing

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Who this might be right for
COVID-19 Disease
Bavarian Nordic 197
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078357
What this trial is testing

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Who this might be right for
Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse Reaction+3 more
University of Sao Paulo General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00109330
What this trial is testing

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 4,116
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT01146119
What this trial is testing

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 200
Not applicableStudy completedNCT05126992
What this trial is testing

EU Secondary Data Post-Authorisation Safety Study of AZD1222

Who this might be right for
COVID-19, Vaccine Adverse Events of Special Interest
AstraZeneca 5,321,930
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00616928
What this trial is testing

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

Who this might be right for
Influenza
GlaxoSmithKline 4,561
Testing effectiveness (Phase 2)Ended earlyNCT05327816
What this trial is testing

Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
Janssen Vaccines & Prevention B.V. 132
Early research (Phase 1)Study completedNCT05178901
What this trial is testing

Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Who this might be right for
Nipah Virus Infection
Public Health Vaccines LLC 60
Testing effectiveness (Phase 2)Study completedNCT02436928
What this trial is testing

Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

Who this might be right for
H7N9 Influenza Vaccine
Medigen Vaccine Biologics Corp. 200
Next Page